Yesterday an article came out on Bloomberg that discussed the issues with reimbursement on Gilead's latest drug, Yescarta. For those who don't know, Yescarta is a CAR-T therapy that was developed by KITE Pharmaceuticals. CAR-T is the hottest space...
Tailwind's Take: this is a $2B market potentially and CYRX is the only pure play, fastest growing and best offering in the space. This could be a multi-year winner.  IRVINE, Calif., March 13, 2017 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX, CYRXW),...
Tailwinds' Take: This announcement was well anticipated, but great news nonetheless. Revenue guidance of $8-10M per annum from this contract is double trailing 12 month revenues, so the upside is huge. Expect to see Kite contract announced in not...
IRVINE, California, February 5, 2018 - Cryoport, Inc. (NASDAQ: CYRX, CYRXW) (“Company”), the world's leading temperature controlled logistics company dedicated to the life sciences industry, today announced that Cryoport will support TiGenix (Euronext Brussels and NASDAQ: TIG) as it...
As we enter the new year it is very difficult not to be optimistic...borderline exuberant. The Tailwinds Select Portfolio has been on a tear lately, closing the year with a bang. If gaining 20% in the last two months...
This video details the competitive strength and upcoming catalysts for CYRX.
It's been a while since we wrote about Cryoport. At that time, the shares of CYRX were on an absolute tear and it had become the largest position in the Tailwinds Select Portfolio, by quite a margin. As such,...
Tailwinds' Take: with recent approvals from Kite and Novartis, along with 20 Phase III drug partnerships, Cryoport is poised to have explosive revenue growth over the next few years. As they say, "Tip of the iceberg." IRVINE, Calif., Nov. 2, 2017 /PRNewswire/...
There's a veritable gold rush going on right now in the area of personalized therapies. Companies like Novartis and Gilead (KITE) were among the first to hit the pay zone, but there's plenty of gold in them thar hills,...
IRVINE, Calif., Oct. 26, 2017 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX, CYRXW) ("Cryoport" or the "Company"), the world's leading cold chain logistics company serving the life sciences industry, today announced the launch of a new website supporting its CryoStork(SM) cryogenic logistics solutions...